Identifying Findings on Brain Scans That Could Help Make Better Predictions About Brain Cancer Progression, The GABLE Trial

This study — called the GABLE Trial — collects MRI brain scan data from patients with newly diagnosed glioblastoma (a highly aggressive brain cancer) to develop better tools using imaging to predict how the cancer will progress. The goal is to improve future treatment planning using AI-driven image analysis. **You may be eligible if...** - You are 18 years or older - You have been newly diagnosed with glioblastoma (IDH wild-type, confirmed by the 2021 WHO criteria) - You are planning to receive standard-of-care treatment for glioblastoma - You have had an MRI scan before your diagnostic surgery and a post-operative MRI within 3 weeks after surgery - Your performance status is adequate (Karnofsky score 60% or higher) **You may NOT be eligible if...** - Your glioblastoma was not newly diagnosed (e.g., recurrent) - You did not have the required MRI scans done - Your performance status is too low Talk to your doctor to see if this trial is right for you.